NAPOLITANO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 6.751
AS - Asia 5.299
EU - Europa 4.461
SA - Sud America 709
AF - Africa 113
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 17.354
Nazione #
US - Stati Uniti d'America 6.648
CN - Cina 3.145
IE - Irlanda 1.110
SG - Singapore 1.023
UA - Ucraina 665
HK - Hong Kong 638
BR - Brasile 574
DE - Germania 505
RU - Federazione Russa 499
IT - Italia 427
FI - Finlandia 384
SE - Svezia 351
GB - Regno Unito 230
VN - Vietnam 166
FR - Francia 141
CA - Canada 64
IN - India 55
JP - Giappone 54
AR - Argentina 53
ZA - Sudafrica 39
BD - Bangladesh 34
MX - Messico 30
AT - Austria 28
IQ - Iraq 27
NL - Olanda 25
EC - Ecuador 21
PK - Pakistan 21
MU - Mauritius 20
PL - Polonia 20
BE - Belgio 18
ID - Indonesia 18
ES - Italia 15
JO - Giordania 15
PY - Paraguay 13
TR - Turchia 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
VE - Venezuela 11
CO - Colombia 10
MA - Marocco 10
PE - Perù 9
KZ - Kazakistan 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
EG - Egitto 7
IR - Iran 7
KE - Kenya 7
TN - Tunisia 7
BO - Bolivia 6
CL - Cile 6
LT - Lituania 6
PT - Portogallo 6
SA - Arabia Saudita 6
EU - Europa 5
SN - Senegal 5
UY - Uruguay 5
GE - Georgia 4
NP - Nepal 4
NZ - Nuova Zelanda 4
AU - Australia 3
BH - Bahrain 3
BW - Botswana 3
DZ - Algeria 3
GR - Grecia 3
IL - Israele 3
KH - Cambogia 3
KR - Corea 3
LV - Lettonia 3
PH - Filippine 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
BY - Bielorussia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CG - Congo 1
CY - Cipro 1
DJ - Gibuti 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
MD - Moldavia 1
Totale 17.339
Città #
Dublin 1.110
Chandler 1.040
Jacksonville 856
Nanjing 718
Hong Kong 636
Dallas 553
Ashburn 515
Beijing 453
Singapore 410
Boardman 384
Nanchang 301
Princeton 259
Lawrence 233
Wilmington 222
Hebei 219
Changsha 192
Shenyang 188
Los Angeles 164
Jiaxing 152
Medford 148
Helsinki 122
Tianjin 122
New York 109
Shanghai 109
Moscow 103
Milan 94
Buffalo 88
Hangzhou 88
Woodbridge 82
Redondo Beach 80
San Genesio Ed Uniti 69
Ann Arbor 63
Ho Chi Minh City 60
São Paulo 50
Norwalk 47
Falls Church 46
Tokyo 46
Falkenstein 44
Verona 42
Munich 40
Seattle 38
The Dalles 38
Brooklyn 36
Chicago 36
Hanoi 36
Nuremberg 33
Houston 30
Pavia 27
Johannesburg 26
San Francisco 26
Des Moines 25
Guangzhou 24
Zhengzhou 23
Kunming 22
Toronto 20
Fairfield 19
Montreal 19
Columbus 18
Stockholm 18
Warsaw 18
Brussels 17
Council Bluffs 17
Jinan 17
Santa Clara 17
Mexico City 15
Washington 15
Amman 14
Atlanta 14
London 14
Rio de Janeiro 14
Boston 13
Chennai 13
Denver 13
Ningbo 12
Phoenix 12
Rome 12
Orem 11
San Jose 11
Tappahannock 11
Tashkent 11
Turku 11
Baghdad 10
Belo Horizonte 10
Brasília 10
Changchun 10
Curitiba 10
Dearborn 10
Dhaka 10
Naples 10
Salvador 10
Taizhou 10
Vienna 10
Buenos Aires 9
Düsseldorf 9
Guayaquil 9
Mumbai 9
Palermo 9
Poplar 9
Frankfurt am Main 8
Haiphong 8
Totale 11.253
Nome #
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 166
Tachicardia Ventricolare Polimorfa Catecolaminergica 150
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 146
A method of gene transfer for the treatment of recessive CPVT 146
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 130
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 125
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 120
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 114
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 110
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 110
Gene-specific therapy for inherited arrhythmogenic diseases 109
Assessment of a personalized and distributed patient guidance system 108
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 107
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 106
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 105
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 105
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 104
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 104
Computer simulation of wild-type and mutant human cardiac Na+ current 103
Risk stratification in the Long-QT Syndrome 102
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 102
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 101
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 101
Information extraction from Italian medical reports: An ontology-driven approach 100
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 99
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 98
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 98
A Recessive Variant of the Romano-Ward Long QT Syndrome 96
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 96
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 95
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 95
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 95
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 94
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 94
Cardiac Sodium Channel Diseases 93
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 93
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 92
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 92
Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact 92
Clinical timelines development from textual medical reports in Italian 92
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 92
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 92
[Role of standard resting ECG in the assessment of sudden cardiac death risk] 91
A molecular basis for the therapy of the long QT syndrome 91
Age and sex-related differences in the clinical manifestations of congenital long QT syndrome: findings from the International Prospective LQTS Registry 91
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 90
Supporting shared decision making within the MobiGuide project. 90
The role of nurses in e-health: The MobiGuide project experience 90
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 89
R Engine Cell: integrating R into the i2b2 software infrastructure. 89
Genetics of ion-channel disorders 89
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 88
CardioVAI: An automatic implementation of ACMG-AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases 88
Evaluation of BLS-D training in lay people. 86
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 86
L-TYPE CALCIUM CHANNEL DISEASE 86
Cardiac Magnetic Resonance in Stable Coronary Artery Disease: Added Prognostic Value to Conventional Risk Profiling 86
A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. 85
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 84
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 84
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 83
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 83
The long QT syndrome 83
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 81
Inherited arrhythmia: present and future perspectives for genetic therapy 81
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 81
Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome 81
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 81
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 81
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 81
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 80
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 80
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 80
Information Extraction from Italian medical reports: first steps towards clinical timelines development 80
Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor (RyR2) 80
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 80
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 79
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 79
Genetic of Long QT, Brugada and Other Channelopathies 79
Timothy Syndrome 79
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 79
RyRCa Leak Limits Cardiac Ca Windows Current Overcoming the Tonic Effect of Calmodulin Mice. 79
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 78
Genetics of Arrhythmogenic Disorders 78
Clinical and research data integration: the i2b2-FSM experience 78
Brugada syndrome 78
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 77
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 77
“Cardiac Risk Stratification by NOS1AP Genotyping” 77
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation 76
Molecular underpinning of ''good luck'' 74
Long QT Syndrome 74
Patient-tailored workflow patterns from clinical practice guidelines recommendations 74
Sodium current disorders: Geneticist's view 74
Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia 74
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 73
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 73
Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. 73
Romano-Ward and other congenital long QT syndromes 73
Inherited calcium channelopathies in the pathophysiology of arrhythmias. 73
Totale 9.179
Categoria #
all - tutte 79.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021869 0 0 0 0 0 175 10 186 77 196 171 54
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/20253.129 58 271 68 88 78 155 191 286 717 128 288 801
2025/20263.606 525 486 919 669 783 224 0 0 0 0 0 0
Totale 17.526